Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis

J Clin Neurol. 2018 Jan;14(1):98-99. doi: 10.3988/jcn.2018.14.1.98. Epub 2017 Sep 27.

Authors

Martina Garnero¹, Sabrina Fabbri², Chiara Gemelli², Luana Benedetti², Giovanni Luigi Mancardi², Angelo Schenone², Marina Grandis²

Affiliations

¹ Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genova, Genova, Italy. [email protected].
² Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genova, Genova, Italy.

No abstract available

Publication types

Case Reports
Letter